Jane Street’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.5M | Sell |
23,711
-820,990
| -97% | -$154M | ﹤0.01% | 3855 |
|
|
2026
Q1 | $167M | Buy |
+844,701
| New | +$163M | 0.02% | 454 |
|
|
2025
Q4 | – | Sell |
-111,535
| Closed | -$19.6M | – | 11098 |
|
|
2025
Q3 | $17.1M | Buy |
111,535
+10,037
| +10% | +$1.52M | ﹤0.01% | 1805 |
|
|
2025
Q2 | $14.2M | Sell |
101,498
-28,436
| -22% | -$3.99M | ﹤0.01% | 1772 |
|
|
2025
Q1 | $19.1M | Buy |
129,934
+57,394
| +79% | +$8.3M | ﹤0.01% | 1348 |
|
|
2024
Q4 | $9.51M | Sell |
72,540
-118,239
| -62% | -$16.6M | ﹤0.01% | 1934 |
|
|
2024
Q3 | $29.7M | Buy |
190,779
+56,436
| +42% | +$9.11M | 0.01% | 985 |
|
|
2024
Q2 | $21M | Sell |
134,343
-177,819
| -57% | -$26.8M | ﹤0.01% | 1280 |
|
|
2024
Q1 | $42.3M | Buy |
312,162
+60,338
| +24% | +$7.99M | 0.01% | 721 |
|
|
2023
Q4 | $33.9M | Buy |
251,824
+70,666
| +39% | +$9.19M | 0.01% | 885 |
|
|
2023
Q3 | $24.5M | Sell |
181,158
-84,451
| -32% | -$11.5M | 0.01% | 945 |
|
|
2023
Q2 | $38M | Buy |
265,609
+23,983
| +10% | +$3.53M | 0.01% | 737 |
|
|
2023
Q1 | $33.5M | Buy |
241,626
+106,884
| +79% | +$14.4M | 0.01% | 687 |
|
|
2022
Q4 | $18.3M | Buy |
134,742
+60,899
| +82% | +$7.64M | 0.01% | 1077 |
|
|
2022
Q3 | $8.1M | Buy |
73,843
+32,756
| +80% | +$4.16M | ﹤0.01% | 1938 |
|
|
2022
Q2 | $5.43M | Sell |
41,087
-22,596
| -35% | -$2.96M | ﹤0.01% | 2544 |
|
|
2022
Q1 | $8.45M | Sell |
63,683
-524,072
| -89% | -$62.8M | ﹤0.01% | 2209 |
|
|
2021
Q4 | $68.5M | Sell |
587,755
-10,448
| -2% | -$1.23M | 0.02% | 516 |
|
|
2021
Q3 | $71.9M | Buy |
598,203
+181,821
| +44% | +$21.2M | 0.03% | 451 |
|
|
2021
Q2 | $49.9M | Sell |
416,382
-43,657
| -9% | -$4.79M | 0.02% | 553 |
|
|
2021
Q1 | $45.7M | Sell |
460,039
-629,403
| -58% | -$63.3M | 0.02% | 515 |
|
|
2020
Q4 | $109M | Buy |
1,089,442
+651,951
| +149% | +$69.1M | 0.05% | 223 |
|
|
2020
Q3 | $47.9M | Buy |
437,491
+378,164
| +637% | +$42.1M | 0.03% | 400 |
|
|
2020
Q2 | $6.28M | Buy |
59,327
+51,040
| +616% | +$5.27M | ﹤0.01% | 1592 |
|
|
2020
Q1 | $740K | Sell |
8,287
-541,309
| -98% | -$51M | ﹤0.01% | 3173 |
|
|
2019
Q4 | $54.8M | Buy |
549,596
+128,863
| +31% | +$12.1M | 0.08% | 161 |
|
|
2019
Q3 | $37.5M | Buy |
420,733
+50,218
| +14% | +$4.35M | 0.06% | 213 |
|
|
2019
Q2 | $30.6M | Buy |
370,515
+340,396
| +1,130% | +$26.7M | 0.05% | 262 |
|
|
2019
Q1 | $2.44M | Buy |
30,119
+10,100
| +50% | +$796K | ﹤0.01% | 1815 |
|
|
2018
Q4 | $1.52M | Buy |
20,019
+11,774
| +143% | +$919K | ﹤0.01% | 2026 |
|
|
2018
Q3 | $653K | Buy |
8,245
+2,917
| +55% | +$221K | ﹤0.01% | 3296 |
|
|
2018
Q2 | $374K | Sell |
5,328
-15,627
| -75% | -$1.12M | ﹤0.01% | 3904 |
|
|
2018
Q1 | $1.47M | Buy |
20,955
+12,364
| +144% | +$856K | ﹤0.01% | 2213 |
|
|
2017
Q4 | $596K | Buy |
8,591
+1,203
| +16% | +$81.1K | ﹤0.01% | 2975 |
|
|
2017
Q3 | $501K | Buy |
7,388
+702
| +10% | +$44.3K | ﹤0.01% | 3097 |
|
|
2017
Q2 | $456K | Buy |
+6,686
| New | +$437K | ﹤0.01% | 3145 |
|
|
2017
Q1 | – | Sell |
-7,760
| Closed | -$452K | – | 4108 |
|
|
2016
Q4 | $424K | Sell |
7,760
-4,160
| -35% | -$236K | ﹤0.01% | 3014 |
|
|
2016
Q3 | $783K | Sell |
11,920
-5,479
| -31% | -$358K | ﹤0.01% | 2251 |
|
|
2016
Q2 | $1.05M | Buy |
+17,399
| New | +$1.01M | 0.01% | 1922 |
|
|
2015
Q2 | – | Sell |
-522,077
| Closed | -$35.7M | – | 3609 |
|
|
2015
Q1 | $35.7M | Buy |
+522,077
| New | +$36.3M | 0.28% | 68 |
|
|
2014
Q4 | – | Sell |
-147,678
| Closed | -$10.6M | – | 2464 |
|
|
2014
Q3 | $10.6M | Sell |
147,678
-1,737,500
| -92% | -$127M | 0.11% | 149 |
|
|
2014
Q2 | $140M | Buy |
1,885,178
+1,819,279
| +2,761% | +$132M | 1.78% | 4 |
|
|
2014
Q1 | $4.28M | Sell |
65,899
-505,236
| -88% | -$32.6M | 0.05% | 284 |
|
|
2013
Q4 | $33.9M | Buy |
571,135
+263,931
| +86% | +$14.3M | 0.49% | 33 |
|
|
2013
Q3 | $16M | Buy |
+307,204
| New | +$15.4M | 0.19% | 83 |
|
Other funds holding AZN
EP
IA
Jane Street's AZN Position: Q2 2026 in Review
Jane Street reduced its AstraZeneca (AZN) stake by 97% in Q2 2026, selling an estimated $154M and leaving 23,711 shares worth $4.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3855.
Jane Street first reported a position in AZN in Q3 2013 and has held it in 45 quarters since. The position peaked at $167M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Jane Street held 23,711 shares of AstraZeneca worth $4.5M as of Q2 2026.
- Jane Street sold 820,990 AstraZeneca shares in Q2 2026, an estimated $154M.
- AstraZeneca made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #3855 holding.
- Jane Street first reported a position in AstraZeneca in Q3 2013 and has held it in 45 quarters since.
- Jane Street's AstraZeneca position peaked at $167M in Q1 2026.
- 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.